A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

NCT06234423 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Solid Tumor

Interventions

DRUG: CUSP06

Sponsor

OnCusp Therapeutics, Inc.